Все публикации

0:26:42

Regulatory requirements & Approval Procedures for New Drugs | Industrial Pharmacy-II | BP702T

0:36:27

Important Short Questions & Answers of Industrial Pharmacy-II (BP702T) | Unit-1&2 | B.Pharm 7th SEM

0:16:46

Certificate of Pharmaceutical Product (CPP or CoPP) | Industrial Pharmacy-II | BP702T

0:02:58

Pharma shorts: SAR of Disopyramide.. Class 1a Antiarrhythmic Agents.. BP 501T

0:03:22

Pharma shorts: SAR of Quinidine.. Class 1a Antiarrhythmic Agents

0:04:07

Pharma shorts: SAR of HMG CoA Reductase Inhibitors.. SAR of Lovastatin and Other Statins

0:28:13

Responsibilities of Central Drugs Standard Control Organization | Industrial Pharmacy-II | BP702T

0:17:31

New Drug Application (NDA) | Introduction Aim Components | Industrial Pharmacy-II | BP702T | L~27

0:15:39

Investigator’s Brochure (IB) | IND Application | Industrial Pharmacy-II | BP702T | L~26

0:13:09

General Considerations for Investigational New Drug Applications | Industrial Pharmacy-II | BP702T

0:21:32

Non-Clinical Drug Development | Regulatory Drug Approval | Industrial Pharmacy-II | BP702T | L~24

0:19:23

Role of Pharmaceutical Regulatory Affair Department | Industrial Pharmacy-II | BP702T | L~20

0:19:15

Regulatory Affairs | Introduction & Historical Overview | Industrial Pharmacy-II | BP702T | L~19

0:18:30

Technology Transfer Agencies in India | Industrial Pharmacy-II | Unit-2 | BP702T | L~18

0:13:08

Approved Regulatory Bodies & Agencies | Technology Transfer | Industrial Pharmacy-II | BP702 | L~16

0:15:03

Premises & Equipments Information in Technology Transfer | Industrial Pharmacy-II | BP702T | L~14

0:18:58

Granularity of Technology Transfer Process | Industrial Pharmacy-II | Unit-II | BP702T | L~13

0:20:50

Quality Risk Management in Technology Transfer | Industrial Pharmacy-II | BP702T | L~11

0:16:08

Technology Transfer Protocol | Industrial Pharmacy-II | Unit-II | BP702T | L~10

0:18:55

Platform Technology | Introduction, Examples, Benefits | Industrial Pharmacy-II | BP702T | L~7

0:19:20

Introduction of SUPAC Guidelines | Level of Changes, Filing, Benefits | Industrial Pharmacy-II | L~6

0:20:12

Pilot Plant Scale Up Considerations for Semi-Solid Dosage Forms | Industrial Pharmacy-II BP702T L~5

0:22:39

Pilot Plant Scale-Up Considerations for Liquid Orals | Industrial Pharmacy-II | BP702T | L~4